Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a ...
Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a ...
8d
Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) and keeping the ...
In a report released yesterday, Larry Biegelsen from Wells Fargo assigned a Buy rating on Bausch + Lomb Corporation (BLCO – Research ...
Bausch + Lomb is projected to generate nearly $860mn in adjusted earnings before interest, taxation, depreciation and ...
Investor's Business Daily on MSN6d
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?Bausch + Lomb stock surged Monday — briefly breaking out — on a report the company is working with advisors to explore a potential sale.
Consumer medical giant Bausch + Lomb may be preparing to sell off its eye care business, which would include contact lens ...
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Health-care companies rose amid deal intrigue. Bausch + Lomb rallied after The Financial Times reported that the maker of contact lenses and other optical equipment was seeking to sell itself to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback